Global mergers and acquisitions (M&A) activity last year was expected to decline from 2019 levels, mainly due to the COVID-19 pandemic and resulting uncertainty around the global economy, trade tensions between the US and China, and the presidential election in the US. However, James Baillieu from Bird & Bird reveals…
List view / Grid view
Exploring Operation Warp Speed, the Trump Administration’s program to expedite R&D, manufacturing and distribution of medical countermeasures for COVID-19.
Heidi West discusses how academia, government and the pharmaceutical industry can work together to potentially repurpose drugs for the treatment of COVID-19.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
Modernisation of microbiological test methods involves far more than just the science. As new systems and technologies become available it becomes increasingly important that potential users can identify not only the technical requirements, but also the business case. Here, Paul Newby, Alice Laures and Lisa Wysocki from GlaxoSmithKline discuss criteria…
The NIH is teaming with the government, biopharmaceutical, life science and non-profit organisations to overcome obstacles and increase success for advancing promising treatments for PD...
KENX announces Computer Systems Validation and Data Integrity Compliance Congress set for Dublin, Ireland
The CSV and Data Integrity Compliance Congress offers customisable, top-notch training for FDA compliance challenges.